Pacira Pharma (PCRX) Tops Q4 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. ANET
6. DUOL
7. SWKS
8. XYZ
9. CVS
10. FISV

Go back to Pacira Pharma (PCRX) Tops Q4 EPS by 8c

Pacira Pharmaceuticals Reports 2016 Financial Results and Provides Business Update

March 1, 2017 7:30 AM EST

-- Phase 4 EXPAREL® study in total knee arthroplasty meets co-primary endpoints for pain control and opioid reduction against an active comparator ---- EXPAREL net product sales up 11% year-over-year ---- EXPAREL net product sales expected to be in the range of $290 to $310 million in 2017 ---- Conference call today at 8:30 a.m. ET --

PARSIPPANY, N.J., March 01, 2017 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals,... More